Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with T

cphi-onlineFebruary 06, 2017

Tag: TSC , Votubia

PharmaSources Customer Service